Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Double Helix

- PMLiVE

A better direction

Could behavioural science be the key to improving patient outcomes?

- PMLiVE

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

- PMLiVE

Genital herpes vaccine candidate promising in phase II

Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus

- PMLiVE

European sites

What makes a country in Europe attractive to life science companies?

- PMLiVE

Measurement: It’s time to get with the real world

We’ve known for years how important it is to exercise, to manage the amount of calories we eat and to sleep well. Over the last five years, we have been...

- PMLiVE

The Italian Job

Therapy efficacy and value-based reimbursement models

- PMLiVE

Paging Dr Millennial

How do millennial doctors compare to previous generations of doctors?

- PMLiVE

ViiV and Janssen take long-acting HIV regimen into phase III

Cabotegravir and rilpivirine injectable-therapy tipped as future blockbuster

- PMLiVE

Amgen says romosozumab on track for 2016 filing

Reports ‘significant’ reduction of fractures in post-menopausal osteoporosis patients

- PMLiVE

Printable pharma

On-demand drug printing could tackle a major issue in pharma

dengue fever mosquito

EMA creates Zika virus task force

Will aid research and development of vaccines and medicines

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links